During these uncertain times, it becomes very important to identify stocks having robust future potential. The past few months have been critical for investors as the outbreak of COVID-19 impacted broader financial markets. However, this stock has ma...
Summary AFT Pharmaceuticals signed an exclusive Maxigesic IV® licensing as well as supply agreement with Medochemie for six European countries. EBOS Group’s revenue rose by 26.5%, and underlying EBITDA increased by 13.4% during FY20. ...
When you buy a small-cap company, there are high chances that you can lose all your money in that particular stock. However, there are also high chances that you can make extraordinary returns. It can be said that this company has managed to dodge th...
Summary Marketer and distributor of healthcare products, EBOS Group, witnessed strong performances from both Healthcare and Animal Care segments in FY20; total revenue grew by 26.5%. With the distribution of healthcare products falling under es...
Summary Hospital hardware sales of Fisher & Paykel have continued to steadily increase over the first four months of FY21 with over 390% cc revenue growth to the end of July compared to pcp. Fisher & Paykel disclosed that, at current ex...
Summary Retirement village operator, Summerset Group Holdings Limited reported underlying profit of $45.1 million, down by 6% on 1H19 while the reported (IFRS) profit after tax was $1 million in 1H20. Summerset closed its five retirement v...
Summary Penny healthcare stocks are volatile, focused on lifting R&D, and centring towards clinical advancements. Medical cannabis player Cannasouth entered a service agreement with leading US cultivation company, EAH Enterprises LLC, tradi...
As we know, the outbreak of COVID-19 impacted several sectors and market players were forced to reshuffle their holdings in a bid to safeguard their investments. Amidst all these, Healthcare sector has shown its resilient nature, and to some extent, ...
Summary The healthcare industry, along with the ICT industry, has been a bright spot in an otherwise challenging environment. AFT Pharmaceuticals’ Maxigesic IV® licensed in six new European nations; regulatory approvals are anticipate...
The impact of COVID-19 outbreak was felt across sectors and the pandemic has derailed future prospects of several companies. Amidst these worries, here is the company which has managed to sail through. The market presence and stable business prospect...
Get a call to receive stock recommendation services from (www.kalkine.co.nz)
